These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33940444)

  • 1. Basic self-disturbance in subjects at clinical high risk for psychosis: Relationship with clinical and functional outcomes at one year follow-up.
    Værnes TG; Røssberg JI; Melle I; Nelson B; Romm KL; Møller P
    Psychiatry Res; 2021 Jun; 300():113942. PubMed ID: 33940444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic self-disturbance trajectories in clinical high risk for psychosis: a one-year follow-up study.
    Værnes TG; Røssberg JI; Melle I; Nelson B; Romm KL; Møller P
    Eur Arch Psychiatry Clin Neurosci; 2022 Sep; 272(6):1007-1019. PubMed ID: 34783878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anomalous self-experiences are strongly associated with negative symptoms in a clinical high-risk for psychosis sample.
    Værnes TG; Røssberg JI; Møller P
    Compr Psychiatry; 2019 Aug; 93():65-72. PubMed ID: 31351243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalous Self-Experiences: Markers of Schizophrenia Vulnerability or Symptoms of Depersonalization Disorder? A Phenomenological Investigation of Two Cases.
    Værnes TG; Røssberg JI; Møller P
    Psychopathology; 2018; 51(3):198-209. PubMed ID: 29730662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic self-disturbance predicts psychosis onset in the ultra high risk for psychosis "prodromal" population.
    Nelson B; Thompson A; Yung AR
    Schizophr Bull; 2012 Nov; 38(6):1277-87. PubMed ID: 22349924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
    Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
    Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.
    Correll CU; Smith CW; Auther AM; McLaughlin D; Shah M; Foley C; Olsen R; Lencz T; Kane JM; Cornblatt BA
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):475-90. PubMed ID: 18928412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic self-disturbances independently predict recovery in psychotic disorders: A seven year follow-up study.
    Svendsen IH; Øie MG; Møller P; Nelson B; Haug E; Melle I
    Schizophr Res; 2019 Oct; 212():72-78. PubMed ID: 31420200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study.
    Pelizza L; Poletti M; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Pupo S; Gebhardt E; Raballo A
    Eur Arch Psychiatry Clin Neurosci; 2020 Apr; 270(3):337-350. PubMed ID: 31055617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic self-disorders in adolescence predict schizophrenia spectrum disorders in young adulthood: A 7-year follow-up study among non-psychotic help-seeking adolescents.
    Koren D; Tzivoni Y; Schalit L; Adres M; Reznik N; Apter A; Parnas J
    Schizophr Res; 2020 Feb; 216():97-103. PubMed ID: 31889574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizotypy and clinical symptoms, cognitive function, and quality of life in individuals with a psychotic disorder.
    Brosey E; Woodward ND
    Schizophr Res; 2015 Aug; 166(1-3):92-7. PubMed ID: 26002072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms.
    Healy C; Byrne J; Raj Suasi S; Föcking M; Mongan D; Kodosaki E; Heurich M; Cagney G; Wynne K; Bearden CE; Woods SW; Cornblatt B; Mathalon D; Stone W; Cannon TD; Addington J; Cadenhead KS; Perkins D; Jeffries C; Cotter D
    Brain Behav Immun; 2024 Mar; 117():175-180. PubMed ID: 38219978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group.
    Yung AR; Phillips LJ; Yuen HP; Francey SM; McFarlane CA; Hallgren M; McGorry PD
    Schizophr Res; 2003 Mar; 60(1):21-32. PubMed ID: 12505135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.